Literature DB >> 2300390

SBLA syndrome revisited.

H T Lynch1, B Radford, J F Lynch.   

Abstract

We have provided an in-depth, longitudinal, clinical/genetic/pathologic investigation of a family consonant with the sarcoma, breast cancer and brain tumors, lung and laryngeal cancer, leukemia, lymphoma, and adrenalcortical carcinoma syndrome. The pattern of cancer expression involves all three germinal layers with transmission through multiple generations. Segregation of these cancers occur in a manner consonant with an autosomal dominant mode of genetic transmission. It is hoped that recognition of the significance of this tumor pattern within families will provide an impetus for cancer surveillance, control, and laboratory research in the quest for clues to biomarkers which correlate with its cancer-prone genotype.

Entities:  

Mesh:

Year:  1990        PMID: 2300390     DOI: 10.1159/000226789

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  4 in total

1.  Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.

Authors:  E D Lustbader; W R Williams; M L Bondy; S Strom; L C Strong
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

2.  Childhood brain tumor: presentation at younger age is associated with a family tumor history.

Authors:  A Sussman; A Leviton; E N Allred; C Aschenbrener; D F Austin; F H Gilles; E T Hedley-Whyte; L N Kolonel; J L Lyon; G M Swanson
Journal:  Cancer Causes Control       Date:  1990-07       Impact factor: 2.506

3.  Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk.

Authors:  Shih-Jen Hwang; Li Shu-Chung Cheng; Guillermina Lozano; Christopher I Amos; Xiangjun Gu; Louise C Strong
Journal:  Hum Genet       Date:  2003-06-11       Impact factor: 4.132

Review 4.  Multiple genetic alterations in human carcinogenesis.

Authors:  T Sugimura; M Terada; J Yokota; S Hirohashi; K Wakabayashi
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.